Catherine Liao

About Catherine Liao

I help clinicians turn advanced cardiovascular diagnostics into differentiated clinical services that fit into real-world practice.Most clinics don’t struggle with access to technology. They struggle with making it usable, repeatable, and sustainable. The gap is not capability. It’s structure.My work focuses on closing that gap, integrating new capabilities into workflow, shaping how they are understood by patients, and designing models that support consistent, longitudinal use over time.What makes this work is the combination of building the technology, commercializing it, and understanding the economics that determine whether it gets used. I’ve built sensing technologies from the ground up, taken products through regulatory clearance and commercialization, and designed models that align with how clinics actually operate. Alongside this, my work in health economics focuses on how incentives shape adoption, and why clinically valuable innovations often fail to scale.Across all of this, the focus is consistent: turning something that is technically possible into something clinicians can build around and patients come back for over time.

Experience

1. Chief Strategy & Commercial Officer

   Conneqt Health

   Sep 2022 — Present

   CONNEQT Health translates arterial science into clinical services that support earlier detection and longitudinal management of cardiovascular risk.I work across product, clinical, and commercial functions to turn arterial measurement into something that is usable in practice. This includes integrating it into workflow, shaping how it is delivered to patients, and structuring it so it can be used consistently over time.This has involved transitioning from device-based sales to subscription and usage-based models, building a clinical service that makes arterial assessment repeatable at the point of care, and designing pricing to align with how clinics operate.I also led the FDA clearance and commercialization of the company’s consumer product, scaling it to over A$2M in its first year, and introducing an in-app subscription model to support ongoing engagement.In parallel, I spearheaded the company’s expansion into maternal health, bringing arterial health into maternal care to support earlier detection and management during pregnancy. This work was selected as a winner the NIH RADx Maternal Health Challenge and received $1M in funding.

Education

• University of Cambridge

  PhD Candidate, Health Economics

  2025 — 2028

• The London School of Economics and Political Science (LSE)

  Master of Science, Executive MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences

  2019 — 2021

• Imperial College London

  Master of Business Administration, Executive MBA

  2010 — 2012